Pubmed Latest “Fatal Skin Rash in Multiple Myeloma Patient Treated with Bortezomib” by satcit 7 January 2024 written by satcit 7 January 2024 73 https://pubmed.ncbi.nlm.nih.gov/38116361 A patient with multiple myeloma developed a severe, fatal skin rash after treatment with the proteasome inhibitor bortezomib. 0 comment 0 FacebookTwitterPinterestLinkedinTumblrRedditWhatsappTelegramEmail satcit previous post “Cerebral Palsy: A Non-Progressive Neurological Disorder Affecting Children’s Movement and Coordination” next post “Recovery from Life-Threatening Ventriculitis Caused by Vancomycin-Resistant Enterococcus Faecium and Multidrug-Resistant Acinetobacter Baumannii in Patient with CSF Shunt” You may also like “Addressing Modifiable Risk Factors to Improve Cardiovascular Outcomes:... 8 January 2024 “Modifiable Risk Factors’ Impact on Cardiovascular Outcomes: A... 8 January 2024 “Semaglutide May Improve Heart Failure in Obese Patients... 8 January 2024 Semaglutide’s Potential Beneficial Effects on Heart Failure with... 8 January 2024 “Semaglutide May Lower Heart Failure Hospitalization Risk in... 8 January 2024 “Semaglutide May Reduce Cardiovascular Risks in Heart Failure... 8 January 2024 “Methemoglobinemia Outbreak in Japanese Neonatal ICU and Maternity... 8 January 2024 “New Perspectives on Medical Ethics: A Commentary in... 8 January 2024 “Balancing Probability and Precision in Designing Future ARDS... 8 January 2024 “Evaluating Doxycycline Postexposure Prophylaxis for Preventing Sexually Transmitted... 8 January 2024 Leave a Comment Cancel Reply Save my name, email, and website in this browser for the next time I comment.